The rationale for the decreased expression of Gal3 in the early stages of pituitary and prostate cancer has been investigated by us and others, and the methylation of DNA in the Gal3 promoter has been shown to be responsible for its decreased expression [91,94,98,99]. This evidence concerns the gene LGALS3 and Familial prostate cancer.